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Ultraviolet (UV) radiation suppresses systemic immunity. We explored these cellular mechanisms by exposing
mice to systemically immunosuppressive doses of UV radiation and then analyzing cell phenotype and function in
the lymphoid organs. Although UV radiation increased total cell number in the draining lymph nodes (DLN), it did
not alter the activation state of dendritic cells (DC). Rather, UV radiation selectively activated lymph node B cells,
with these cells being larger and expressing higher levels of both anti-major histocompatibility complex II and B220
but not co-stimulatory molecules. This phenotype resembled that of a B cell geared toward immune tolerance. To
test whether UV radiation-activated B cells were responsible for immunosuppression, DC and B cells were con-
jugated to antigen ex vivo and transferred into naI¨ve hosts. Although DC by themselves activated T cells, when the
B cells from UV radiation-irradiated mice were co-injected with DC, they suppressed DC activation of immunity.
Interleukin (IL)-10-activated B cells also suppressed DC induction of immunity, suggesting that IL-10 may be
involved in this suppressive effect of UV radiation. These results demonstrate a new mechanism of UV radiation
immunosuppression whereby UV radiation activates B cells in the skin-DLN that can suppress DC activation of T
cell-mediated immunity.
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The ultraviolet (UV) wavelengths in sunlight are a major hu-
man health concern because they cause both DNA damage
and immunosuppression, both of which are required for the
development of skin cancers (Kripke, 1994). UV radiation is
divided into three wavebands, UVC (o290 nm), UVB (290–
320 nm), and UVA (320–400 nm), with visible light being
made up of even longer wavelengths. UVC is blocked by the
ozone layer and does not reach the Earth’s surface so sun-
light is a mixture of UVB and UVA.
UV suppresses the induction of local and systemic im-
mune responses as well as reactivation of immunological
memory (Damian et al, 1999; Byrne et al, 2002). UV-induced
‘‘local immunosuppression’’ is observed when an area of
skin (e.g., dorsum) is irradiated followed by application of
antigen to the same skin site. This paper has studied sys-
temic immunosuppression that is observed when one site
receives the UV (e.g., dorsum) but the antigen is applied to a
site that did not receive the UV (e.g., abdomen). This proc-
ess is mediated via a cascade release of cytokines including
interleukin (IL)-4 and IL-10 that culminate in the activation of
suppressor cells in secondary lymphoid tissues (Shreedhar
et al, 1998; Moodycliffe et al, 2000). The cellular events in-
volved in the activation of these suppressor cells, however,
remain unclear. It is known that UVB can suppress the pro-
duction of IL-12 by lymph node dendritic cells (DC) (Kit-
azawa and Streilein, 2000; Schmitt and Ullrich, 2000), which
is likely to be an important event because DC can activate
effector-, and in certain circumstances, regulatory T cells
(Martin et al, 2003).
B cells are an important lymph node antigen-presenting
cell (APC) normally responsible for activating secondary
immune responses and producing antibody. But recent ev-
idence also implicates B cells in the regulation of immune
responses. IL-10-secreting B cells were found to regulate
chronic intestinal inflammation (Mizoguchi et al, 2002) as
well as temper the severity of autoimmune disorders (Fill-
atreau et al, 2002; Mauri et al, 2003). More importantly, there
is now increasing evidence that B cell-dependent immune
regulation may be mediated via inhibition of DC function
(Moulin et al, 2000). In light of this intriguing possibility, we
have investigated whether immunosuppressive doses of
solar-simulated UV (ssUV) radiation alters the activation
state of DC subsets and B cells in draining lymph nodes
(DLN), and whether this alteration is responsible for inducing
a state of immunological inactivity. We show for the first
time that UV radiation activates B cells in the DLN and that
these cells inhibit the induction of T cell immunity by DC.
Abbreviations: APC, antigen-presenting cell; CS, contact sensitiv-
ity; DLN, draining lymph node; FCS, fetal calf serum; HBSS,
Hanks-buffered salt solution; IL, interleukin; LC, Langerhans cells;
MHC, anti-major histocompatibility complex; ssUV, solar simulated
ultraviolet radiation; Th1, T-helper type 1; TNCB, tri-nitro-chloro-
benzene; TNP, tri-nitro-phenol; UV, ultraviolet
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Results
Immunosuppressive ssUV alters DLN but not splenic or
thymic cell numbers We first verified that 18200 mJ per
cm2 of ssUV causes systemic immunosuppression (Fig 1).
The contact sensitivity (CS) response to both tri-nitro-
chloro-benzene (TNCB) and oxazolone was suppressed
39% and 53%, respectively, by ssUV, showing that UV
immunosuppression was not dependent on a particular
antigen.
Comparisons between lymphoid organs of unirradiated
and ssUV-exposed mice showed that whereas there was
no alteration in spleen or thymus weights or total cell num-
bers, there was a significant increase in DLN weights
(5.1  0.3  103 vs 7.7  0.5  103 g, respectively;
n¼12) and cellularity (Fig 2). This increase in DLN size
and cell numbers was not because of differences in body
weights between unirradiated control groups and UV-irra-
diated mice (19.6  0.3 and 19.8  0.4 g, respectively;
n¼12).
ssUV alters the APC in DLN No significant alteration
in splenic or thymic APC subsets was found following
ssUV (data not shown). We identified total DLN DC as
CD11cþMHC IIþ (MHC, anti-major histocompatibility com-
plex), whereas B cells were CD11c–MHC IIþB220þ (Fig 3A
and C). The total number of DC increased by almost 30%,
whereas B cells increased by over 40% following exposure
to ssUV (Fig 3B). This meant that ssUV increased the DLN
ratio of B cells to DC from 4.7:1 to 5.5:1 (po0.05; n¼31 and
32, respectively).
To confirm that we were correctly identifying B cells, DLN
cell suspensions were labelled with other traditional B cell
markers (Fig 3C). The CD11c–MHC IIþ cells in the lower
right quadrant of Fig 3A were also B220þ , CD19þ , and
IgDþ . This observation could not have been a result of
doublet formation, with the presence of ethylenediamine-
tetraacetic acid (EDTA) and PI staining verifying single cells.
Additionally, these B cells were completely negative for the
traditional T cell markers CD4 and CD8-a (Fig 3C). Further
characterization to identify the subset of B cells found in the
DLN of mice exposed to ssUV showed that whereas all B
cells expressed high levels of both IgD and IgM (data not
shown), they were almost completely negative for both CD5
and CD43 (1.6  0.1% and 1.8  0.1% double positive for
No UV and ssUV, respectively). Hence, B cells in the lymph
nodes of both control and ssUV-irradiated mice are con-
ventional B cells.
ssUV irradiation does not affect the number of phagocy-
tic cells in the DLN We were interested in determining
whether ssUV affects the ability of DLN cells to phagocy-
tose particles. To test this, control and ssUV-irradiated mice
were injected with fluorescent latex microspheres 18 h prior
to the removal and analysis of DLN cells. Although ssUV
reduced the total percentage of phagocytic cells in the DLN
Figure 1
Eighteen thousand two hundred mJ per cm2 of solar-simulated
ultraviolet (ssUV) is immunosuppressive in C57BL/6 mice. Groups
of five to six mice were shaved on their dorsal trunk and exposed to
three consecutive daily doses of 18200 mJ per cm2 ssUV, which were
comprised of 1400 mJ per cm2 UVB and 16800 mJ per cm2 UVA. Three
days following the final UV irradiation, the abdomens of both control
unirradiated and UV-irradiated mice were shaved and the contact sen-
sitizers tri-nitro-chloro-benzene (TNCB) or oxazolone were applied
topically. Seven days later the right ear of each mouse (including an
unsensitized irritant control group of mice) was challenged to the sen-
sitizing antigen. The increase in ear thickness compared with the un-
challenged left ear was measured 24 h later, and the response in irritant
control mice was subtracted to assess immunity. MeanþSEM; n¼ 17
for TNCB treatment (pool of three separate experiments), n¼ 5 for ox-
azolone treatment. po0.05 compared with unirradiated control.
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Solar-simulated ultraviolet (ssUV) does not affect spleen or thymus
cell numbers, but significantly increases draining lymph node
(DLN) cellularity. Groups of two mice were irradiated with ssUV or
unirradiated. Three days after the last UV, corresponding exactly with
the time that antigen would normally be applied to test for immune
suppression, the spleen, thymus, and inguinal skin-draining lymph
nodes were removed and made into cell suspensions and cell counts
were performed. MeanþSEM of total cell counts for spleen (  108),
thymus (  108), and DLN (  106) are shown for six repeats (n¼12).
po0.05 compared with unirradiated controls.
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by 50% (Fig 4A), the absolute number of phagocytic cells in
the DLN was unaffected by ssUV (Fig 4C). A detailed anal-
ysis of these cells showed that ssUV did not alter the ratio
nor the number of B cells or DC that had phagocytosed
beads in vivo (Fig 4B and C). Furthermore, B cells from
either control or irradiated groups could both phagocytose
particles in vivo (Fig 4B). The implications of these findings
are 2-fold. First, they suggest that ssUV does not cause
immunosuppression by altering the ability of lymph node
APC to phagocytose antigen in vivo; and second, they show
that the increase in cellularity that accompanies ssUV-in-
duced immunosuppression is not because of the infiltration
of the DLN by phagocytic cells.
ssUV alters the phenotype of B cells but not DC ssUV
did not alter the distribution of DC subsets, or the phe-
notype of DC in the DLN compared with control groups.
We identified the four main DC subsets in the DLN
as CD11clowB220þ IgD (the so-called murine plasmacy-
toid DC that were also Gr-1þ ), CD8-aþCD11cþ ,
CD4þCD11cþ , and CD11cþ DC, which were negative for
all three of these lymphoid markers (Fig 5A). ssUV did not
affect the subsets as a percentage of total DC (Fig 5B).
Moreover, ssUV did not alter the activation state of DC in
the DLN as the levels of MHC II and co-stimulatory mole-
cules (CD80 and CD86) were unaffected by ssUV (Fig 5C).
Thus, whereas ssUV increased the total number of DC in
the DLN, this was not specific for any particular subset, and
these DC were not activated.
Compared with CD11cþMHC IIþ DC, DLN B cells ex-
pressed low levels of the co-stimulatory molecules CD80
and CD86 (Fig 6A). Similar to DC, this expression was not
significantly altered by ssUV (Fig 6C). In contrast to DC,
however, we found that ssUV significantly increased the
expression of MHC II and B220 on DLN B cells (Fig 6B and
C). Additionally, lymph node B cells were larger, as they had
increased forward and side scatter profiles (Fig 6B). These
results show that ssUV does not alter the activation state of
DC, but rather activates B cells in the DLN so that they
become larger and express significantly higher levels of
MHC II and B220.
DLN B cells activated by ssUV suppress DC initiation of
T cell-mediated immune responses To test whether the B
cells activated by ssUV play a functional role in UV-induced
immunosuppression, DLN DC and B cells from both control
and ssUV-irradiated mice were purified with CD11c micro-
beads (Fig 7A), conjugated to antigen ex vivo, and injected
into naı¨ve syngeneic hosts to test their ability to activate
immunity. Seven days later, the magnitude of the immune
response induced by the antigen-coupled APC was tested
by applying antigen (TNCB) to the surface of one ear and
24 h later measuring the increase in ear thickness. Whereas
B cells from neither control nor ssUV-irradiated mice could
activate effector T cells by themselves (Fig 7B, column 3),
DC from both of these groups were able to induce signif-
icant levels of CS (Fig 7B, row 1). When the activated B cells
from UV-irradiated DLN were combined with the DC from
either control or UV-irradiated mice, however, they sub-
stantially inhibited the ability of these DC to activate immu-
nity (Fig 7B, row 3). In contrast, B cells isolated from normal
control mice did not inhibit immune induction when they
were combined with DC (Fig 7B, row 2). It appears that there
was a slight decrease in the level of immunity generated in
mice that received DC from ssUV-irradiated mice together
with B cells from unirradiated mice (Fig 7B, row 2, column 2).
But this was not statistically different compared with groups
that received ssUV DC only (Fig 7B, row 1, column 2;
p¼0.453), nor compared with groups that received a com-
bination of No UV DC and No UV B cells (Fig 7B, row 2,
column 1; p¼0.2846). Moreover, there was a significant
difference between groups that received ssUV DC only,
Figure 3
Solar-simulated ultraviolet (ssUV) alters the
number of antigen-presenting cells (APC) in
the draining lymph node (DLN). (A) DLN single
cell suspensions were labelled for CD11c and
anti-major histocompatibility complex (MHC) II to
identify the two major APC subsets (CD11cþMHC
IIþ dendritic cells (DC) and CD11c–MHC IIþ B
cells). The percentage of both DC (n¼44 mice,
pooled from 11 separate experiments) and B cells
(n¼32 mice, pooled from eight separate experi-
ments) is shown in the upper right and lower right
quadrants, respectively. (B) Total number of DC
(n¼44 mice, pooled from 11 separate experi-
ments) and B cells (n¼ 32 mice, pooled from eight
separate experiments) in the DLN was calculated
by multiplying the percentage of each APC by the
total number of DLN cells for each mouse. Indi-
vidual experiments contained groups of four mice
either control unirradiated (open bars) or exposed
to ssUV (solid bars). MeanþSEM are shown;
po0.05 compared with unirradiated control. (C)
Three- and four-color flow cytometry confirmed
the CD11c–MHC IIþ B cells as B220þ , CD19þ ,
IgDþ , CD4–, and CD8-a (positive staining is
shown by the shaded histograms and isotype
staining is shown by the open histograms). PI
staining verified that analysis was of single cells.
Representative histograms are shown.
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or ssUV DC together with No UV B cells and groups that
received ssUV DC and ssUV B cells (Fig 7B, row 3, column
2; p¼ 0.0338 and 0.0366, respectively). These comparisons
support our theory that B cells from ssUV-irradiated mice
but not normal B cells can suppress DC initiation of immu-
nity. Similar results were obtained when these experiments
were repeated using a different contact antigen (fluorescein
isothyicyanate (FITC); results not presented). To verify that
this B cell-mediated suppression of DC function was not
a result of contaminating DLN T cells, we further purified
B cells and T cells from ssUV-irradiated mice using CD90
microbeads (Fig 7C). The addition of T cells from ssUV-
exposed mice did not affect the ability of DC to activate
tri-nitro-phenol (TNP)-specific cells (Fig 7D, row 3). Further-
more, DC that were not incubated with the antigen ex vivo
did not activate immunity (Fig 7D, row 2). These results
show that DC from the DLN of ssUV-irradiated mice, in the
absence of B cells, can function normally. More importantly,
they demonstrate that UV-activated B cells (but not resting
B cells from control mice or T cells from ssUV-exposed
mice) inhibit DC-mediated activation of immunity.
To test whether IL-10 could induce a similar activated
phenotype and suppressive function in B cells, freshly
isolated naI¨ve B cells were incubated for 24 h in IL-10
containing RPMI tissue culture media. Similar to ssUV irra-
diation, IL-10 upregulated both MHC II and B220 on B cells
(Fig 8A). Moreover, when IL-10-activated B cells were co-
injected with freshly isolated, TNP-conjugated DC, they
were able to suppress the induction of immunity (Fig 8B). B
cells by themselves did not activate immunity. Antigen on
B cells was not required to suppress DC induction of
Figure 4
Solar-simulated ultraviolet (ssUV) irradiation does not affect the
number of phagocytic cells in the draining lymph node (DLN). (A)
Control mice (n¼ 6) or mice exposed to ssUV (n¼5) were injected with
fluorescent latex beads i.v. 18 h prior to the removal of the DLN to
analyze phagocytic ability of the antigen-presenting cells. Identical
non-fluorescent negative control latex beads were injected into some
mice to determine background fluorescence. Figures in the upper right
corner refer to the absolute percentage of beadþ cells in the DLN.
Representative dotplots shown. (B) Three- and four-color flow cytome-
try allowed for the detection of beadþCD11c–B220þ B cells and
beadþCD11cþ dendritic cells (DC). Figures above the gates refer to
the percentage of beadþ cells. (C) Total number of phagocytic cells
and phagocytic DC or B cells was determined by multiplying the per-
centage by the total number of DLN cells. Results of two separate and
pooled experiments are shown; po0.05 compared with unirradiated
control.
Figure5
Solar-simulated ultraviolet (ssUV) does not alter the phenotype or
subset distribution of draining lymph node dendritic cells (DLN
DC). (A) DC subsets in the DLN were identified by three- and four-color
flow cytometry first as CD11cþ anti-major histocompatibility complex
(MHC) IIþ and then using IgDB220þ for plasmacytoid DC, CD8aþ ,
CD4þ or negative for all three lymphoid markers. (B) ssUV did not alter
the ratio of the various DC subsets in the DLN (meanþSEM are shown,
n¼ 12 from a pool of six separate experiments). (C) ssUV did not alter
the levels of MHC II or the co-stimulatory molecules CD80 or CD86 on
total DC preparations (meanþSEM are shown, n¼12 from a pool of
three separate experiments). Fluorescence intensities of cells from
ssUV-irradiated mice were normalized to the mean fluorescent intensity
of cells from control unirradiated mice. SEM not obvious are too small
to be seen.
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Figure 6
Solar-simulated ultraviolet (ssUV) activates draining lymph node
(DLN) B cells. (A) Anti-major histocompatibility complex (MHC)
IIþB220þCD11c B cells were labelled by four-color flow cytometry
for the co-stimulatory molecules CD80 and CD86. The levels of co-
stimulatory molecule expression on DLN B cells (shaded histogram)
compared with CD11cþMHC IIþ dendritic cells (DC) (bold line open
histogram) are shown for comparison. Isotype control staining on B cells
is indicated by the thin-lined open histogram. (B) Change in expression
of MHC II and B220 on B cells from control mice (open histogram)
compared with ssUV-irradiated mice (shaded histogram). Forward ver-
sus side scatter profiles for B cells are shown in the two lower dotplots.
The figure in the upper left corner is the percentage of B cells with a
relatively high forward and side scatter profile. (C) ssUV did not alter the
levels of co-stimulatory molecules CD80 or CD86 on DLN B cells
(meanþSEM are shown, n¼12 from a pool of three separate exper-
iments). MHC II and B220 were significantly upregulated on DLN B cells
from ssUV-irradiated mice (n¼32, pooled from eight separate exper-
iments). MeanþSEM are shown (SEM not obvious are too small to be
seen); po0.05 compared with unirradiated control mice. Fluorescence
intensities of cells from ssUV-irradiated mice were normalized to the
mean fluorescent intensity of cells from control-unirradiated mice.
Figure7
Solar-simulated ultraviolet (ssUV)-activated draining lymph node
(DLN) B cells inhibit dendritic cells (DC) induction of T-helper type 1
(Th1) immunity. (A) DC and B cells from the DLN of both control un-
irradiated and ssUV-irradiated mice were purified using CD11c
immunomagnetic beads. Typically, there was less than 0.25% con-
taminating DC in the B cell fractions and less than 3% contaminating
anti-major histocompatibility complex (MHC) IIþCD11c– B cells in the
DC fraction. (B) DC or B cells were then conjugated to tri-nitro-phenol
(TNP) in vitro before 105 of each APC or a combination of each was
injected i.v. into syngeneic naı¨ve hosts. The top row shows the result
when DC in the absence of B cells (n¼8 for No UV and n¼ 18 for ssUV
donor DC) were injected into recipients. The second row shows the
result when B cells from control unirradiated mice were injected either
alone (n¼ 9; last column), or in combination with control DC (n¼6; first
column) or DC from ssUV-irradiated mice (n¼ 9; middle column). The
third row shows the result when B cells from ssUV-irradiated mice were
injected either alone (n¼ 8; last column), in combination with control DC
(n¼9; first column), or DC from ssUV-irradiated mice (n¼10; middle
column). The fourth row shows a control showing the result when both
B cell groups were co-injected (n¼ 6). Results are a pool of three sep-
arate experiments. (C) DLN cells from ssUV-irradiated mice were pu-
rified for B cells and T cells by a two-step process using CD11c
followed by CD90 microbeads. Both B cells and T cell fractions were
greater than 95% pure. (D) DC, B cells, and T cells from ssUV-irradiated
mice conjugated to TNP ex vivo or DC purified but not conjugated to
TNP were then injected either alone (rows 1 and 2 for DC; n¼9 and 6)
or in combination with T cells (row 3; n¼ 7) or B cells (row 4; n¼7). For
all experiments, the mean change in ear thickness with irritant control
groups subtractedþSEM is shown (irritant control absolute mean was
9.3  0.9 per mm2; n¼ 20). SEM not obvious are too small to be seen.
po0.05 compared with the irritant control group, NS, not significant;
N/A, not applicable. Representative dotplots from ssUV-irradiated mice
are shown.
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immunity, as this phenomenon was observed when B cells
were either exposed to antigen (Fig 7B and D) or not ex-
posed to antigen (Fig 8B). There was, however, an absolute
requirement for antigen to be present on the DC for both
immunosuppression and activation of immunity (Fig 7D).
These results show that both ssUV and IL-10 activate lymph
node B cells that are able to suppress DC induction of T cell
immunity.
Discussion
UV radiation from the sun is one of the most damaging
environmental carcinogens to which humans are exposed.
In these experiments, we used a solar-simulated source of
UV that provides an excellent reproduction of the UV portion
of sunlight to demonstrate a new mechanism of how UV
causes systemic immunosuppression. This process in-
volves the activation of lymph node B cells that in turn
suppress DC-mediated activation of T cell immunity.
Our data show that systemically immunosuppressive
ssUV alters the cells in the lymph node draining UV-irradiat-
ed skin but not the spleen or thymus. ssUV clearly increased
the total DLN cell numbers, as well as the total number of
all subsets of DC and B cells. A thorough phenotypic anal-
ysis of DLN B cells identified them as B220þMHC
IIþCD19þ IgDþ IgMþCD11c–CD4–CD8–CD5–CD43–. The in-
crease in DLN cellularity is particularly interesting consid-
ering that this occurred in the absence of antigenic stimuli.
The mechanism of how ssUV increases DLN cell numbers is
unclear, but is almost certainly a prerequisite for the immune
suppression that ensues. One possibility is that the increase
in the number of DC and B cells was a result of migration of
these cells from other organs. This hypothesis is supported
by earlier experiments that showed that UVB induced
changes in splenic adherent cells such that they activated
suppressor T cells after trafficking from the spleen to the
DLN (Greene et al, 1979; Gurish et al, 1982). Although we
cannot rule out the possibility that ssUV has a similar effect
on B cells and DC trafficking from the spleen to the DLN, we
did not see any corresponding reduction in the number of
spleen leukocytes. An alternative hypothesis is that the B
cells migrated directly from the blood, lymph, or other
lymph nodes as a consequence of ssUV induced ‘‘shut-
down’’ of the lymph nodes.
In addition to the increase in cell numbers in the DLN,
ssUV induced the selective activation of B cells, but not DC.
We found that a significant proportion of the DLN B cells
showed typical signs of cellular activation, with an increase
in cell size, and upregulated expression of MHC II mole-
cules (as well as B220). No concomitant increase in ex-
pression of the co-stimulatory molecules CD80 and CD86,
however, was observed. This is potentially very important,
as MHC II upregulation in the absence of adequate co-
stimulatory molecule expression is thought to preference
the induction of tolerance, rather than immunity (Croft et al,
1997). The ssUV-induced upregulation of B220 on B cells
that we observed is particularly striking. B220 is one of the
isoforms of CD45 created by alternate splicing. CD45 is a
signal transduction molecule that regulates responses to
antigen, integrin, and cytokine receptors, controlling the
relative threshold of sensitivity to a variety of stimuli. It is a
receptor-type protein tyrosine phosphatase involved in in-
itiating immune responses in B and T cells (Hermiston et al,
2003). The role that B220 plays in ssUV-induced immune
suppression, however, remains unclear. It is possible that
ssUV initially triggers an increase in the systemic levels of
both IL-4 and IL-10 (Shreedhar et al, 1998), which in turn
increases the size and number, and upregulates the ex-
pression of MHC II and CD45 on B cells (Clark et al, 1989;
Go et al, 1990). Indeed, this hypothesis is supported by our
evidence that IL-10 activates B cells so that they have a
phenotype similar to that of B cells isolated from ssUV-ir-
radiated mice, and that these IL-10-activated B cells can
also suppress DC induction of T cell immunity. The end re-
sult is to make lymph node B cells more susceptible to
activation in response to antigen and thus contribute to the
T-helper type 1 (Th1) to Th2 switch triggered by UV.
In addition to the obvious importance of these findings to
skin carcinogenesis, ssUV-induced B cell activation may
have consequences for the development of other tumors.
Continual exposure to solar radiation may provide chronic
activation signals to B cells. When this is combined with the
immunosuppressive effects of such UV exposure, it is
Figure 8
Interleukin (IL)-10-activated lymph node B cells inhibit dendritic
cells (DC) induction of T helper type 1 immunity. (A) B cells were
purified from naI¨ve inguinal lymph nodes using CD11c and CD90
immunomagnetic beads similar to what is described for Fig 7C. Ex-
pression of anti-major histocompatibility complex (MHC) II and B220 is
shown for B cells cultured in IL-10 for 24 h (closed histogram) or control
RPMI only (open histograms). Figures refer to the mean fluorescence
intensity. (B) DC were isolated from naI¨ve inguinal lymph nodes, purified
using CD11c immunomagnetic beads similar to what is described for
Fig 7A, and conjugated to tri-nitro-phenol. DC were then co-injected i.v.
with either IL-10 cultured (row 3; n¼5) or RPMI-cultured (row 2; n¼5)
B cells. Some groups received IL-10 B cells (row 5; n¼ 6) or RMPI B
cells only (row 4; n¼5). Irritant control groups are also shown (row 1;
n¼6). MeanþSEM are shown.
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perhaps not surprising that epidemiological studies have
found an association between sunlight exposure and the
development of non-Hodgkin’s lymphoma, about 80% of
which are B cell derived (Bentham, 1996; McMichael and
Giles, 1996). Further supporting this hypothesis is the fact
that UV irradiation of mice with only one functional copy of
p53 increases the incidence of lymphoid malignancies, in-
cluding B lymphocyte-derived tumors (Jiang et al, 2001).
Interestingly, in contrast to B cells, we did not observe
any changes in the phenotype of DC in the DLN of ssUV-
irradiated mice. Additionally, whereas the total number of
DC increased, the actual percentage of DC with respect to
all the other cells in the DLN actually decreased; thus, the
ratio of DC to B cells decreased after ssUV. More impor-
tantly, there was no selective effect of ssUV on any one
particular subset of DC. This means that ssUV does not
cause systemic immunosuppression by altering DC pheno-
type or changing the balance of different DC subsets.
Exposing mice to ssUV had no effect on the ability of
lymph node DC or B cells to phagocytose latex particles.
We tested this by injecting control or irradiated mice with
fluorescent latex beads 18 h prior to analysis. This tech-
nique has previously been used by us to successfully track
phagocytic DC and macrophages infiltrating murine skin
tumors (Byrne and Halliday, 2003). We found that exposing
mice to ssUV had no affect on the number of phagocytic
cells in the DLN. Although we did not directly analyze lymph
node macrophages, it would appear from our data that
phagocytic cells are not responsible for this UV-induced
suppressive phenomenon. B cells from control and ssUV-
irradiated mice were equally able to phagocytose the latex
beads, as were DC from control and irradiated mice. Thus,
we can rule out the possibility that ssUV suppresses im-
munity by altering the ability of B cells (or DC) to take up
antigen.
UVB-induced immune suppression has long been asso-
ciated with a switch from a Th1 cell mediated to a Th2-type
humoral immune response (Ullrich, 1996). To test whether
the B cells activated by ssUV were able to suppress Th1
immunity, we isolated the various APC subsets, conjugated
them to antigen ex vivo, and used them to prime naı¨ve mice.
Interestingly, DC from both control and ssUV-irradiated
groups, in the absence of activated B cells, were able to
activate effector T cells in a typical Th1-mediated CS. This
was somewhat surprising, because UVB has been shown to
inhibit lymph node DC secretion of IL-12 (Kitazawa and
Streilein, 2000; Schmitt and Ullrich, 2000). The mechanism
of this altered DC function, however, has never been elu-
cidated. We suspect that the activated B cells inhibit DC-
initiated Th1 immunity by interfering with IL-12 secretion.
This hypothesis is supported by numerous independent re-
ports showing that B cell-deficient mice have increased DC-
derived IL-12 (Moulin et al, 2000) and that whereas T cells
potentiate IL-12 secretion by DC, B cells have the opposite
effect (Rizzitelli et al, 2002). Indeed, it has only recently been
shown that sustained IL-12 release is absolutely required for
Th1 development (Athie-Morales et al, 2004). Any interfer-
ence to this release of IL-12 could have major implications
for the type of immune response that develops. To this end,
we showed that when the ssUV-activated B cells were
combined with the DC from either group, activation of the
Th1 response was inhibited. The mechanism for this reg-
ulatory activity by activated B cells is unclear, although there
is now considerable evidence that regulatory and effector B
cells do exist and that they can regulate immune responses
via secretion of IL-10 (Harris et al, 2000; Fillatreau et al,
2002; Mizoguchi et al, 2002; Mauri et al, 2003). Therefore,
our data now provide strong support for the hypothesis
that ssUV (and the subsequent systemic release of IL-10)
switches immunity from a Th1- to a Th2-type response by
activating B cells that inhibit DC induction of cellular im-
munity. B cell-deficient mice do not mount a CS response
(Tsuji et al, 2002) and therefore it cannot be tested whe-
ther these mice are resistant to systemic UV immuno-
suppression.
In conclusion, we have provided evidence for a novel
mechanism of UV-induced immune suppression, one that
involves the activation of B cells in the DLN that in turn
regulate the initiation of the Th1 immune response via the
inhibition of DC function. It suggests that ssUV ‘‘primes’’ the
DLN for the arrival of antigen, such that if and when it ar-
rives, the DLN is already set along the path of suppression
rather than activation. In order to take advantage of this
pathway for potential therapeutic intervention, it is neces-
sary to explore the mechanisms of how these B cells be-
come activated, and how they exert their regulatory activity
on DC.
Materials and Methods
Mice Female C57BL/6 mice (Animal Resource Centre, Perth, WA,
Australia) aged 8–10 wk at the start of irradiations were used with
the approval of the Sydney University animal ethics committee.
UV source The ssUV spectrum used in this study was produced
with a 1000 W xenon arc solar simulator (Oriel, Stratford, Con-
necticut) as we have described previously (Byrne et al, 2002). The
timing of UV exposure (in s) was adjusted with an automated timing
device so that a dose of ssUV known to cause maximal immuno-
suppression could accurately be delivered to individual mice
(Byrne et al, 2002).
UV irradiations For each experiment, groups of eight C57BL/6
mice had their back-skin hair removed using animal clippers (Oster,
McMinnville, Tennessee) and then a close shave electric razor
(Remington, Madison, Wisconsin) 24 h prior to irradiation. Two
mice at a time were placed in a black Perspex animal-restraining
device fitted with a quartz glass lid for exposure to the UV radi-
ation. The ears and head were shielded from the UV with black
Perspex. Irradiation times were about 30 s and a combination of
fans and air-conditioning maintained body temperature during ir-
radiation. Control unirradiated mice were shaved and restrained
only. Mice were irradiated with 18200 mJ per cm2 of ssUV (made
up of 1400 mJ per cm2 UVB and 16800 mJ per cm2 UVA) each day
for 3 consecutive days. Three days after the final UV irradiation,
mice were either euthanized by cervical dislocation or contact
sensitized.
Determination of immunosuppression by CS Mice that had re-
ceived three consecutive doses of UV to the back-skin were sen-
sitized to antigen by applying 50 mL of a 4% wt/vol solution of
TNCB (ICI Chemical, Tokyo, Japan) dissolved in 4:1 acetone:olive
oil. To verify that the UV-induced immunosuppression occurred
with another antigen, a separate group of mice was given 50 mL of
a 2% wt/vol solution of 4-Ethoxymethylene-2-pheyl-2-oxazolin-5-
one (oxazolone; Sigma Chemical, St Louis, Missouri) dissolved in
acetone. These haptens were applied to the shaved unirradiated
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abdomen 3 d after the final UV exposure, with positive control
unirradiated mice being sensitized in the same way. To assess CS,
10 mL of a 1% solution of TNCB in 4:1 acetone:olive oil or 5 mL of
the 2% oxazolone solution was applied to both sides of the right
ear of the mice 7 d later. After a further 24 h, the difference in
thickness between the right challenged and left unchallenged ears
was measured using engineers callipers (Mitutoyo Corporation,
Kanagawa, Japan). The increase in ear thickness of negative con-
trol unirradiated, unsensitized but challenged only mice (irritant
control) were subtracted from the test groups.
Phagocytosis by lymph node APC in vivo Fifty four hours after
the last UV irradiation, 200 mL of Fluoresbrite Carboxy YG or con-
trol non-fluorescent 2.6% solid latex microspheres with a diameter
of 0.5 mm (Polysciences; Warrington, Pennsylvania) were injected
i.v. into either UV-irradiated or control unirradiated mice. In these
experiments, mice were not sensitized to antigen. Inguinal, back-
skin DLN were then removed 18 h later (3 d after last UV) and made
into single cell suspensions. The inguinal lymph nodes drain the
site of UV irradiation (dorsum). Lymph nodes were teased apart
with needles and then incubated in 1 mL of a 2% fetal calf serum
(FCS)/Dulbecco’s modified Eagle’s medium (DMEM) (Trace Bio-
sciences, Melbourne, Australia) solution containing 1 mg Colla-
genase II (Worthington Biochemical Corporation, Lakewood, New
Jersey) and 0.1 mg DNAse (Sigma Chemical). The cell suspension
was periodically mixed at room temperature for 25 min before
adding 85 mL of 0.1 M EDTA (Sigma Chemical) for the final 5 min of
the incubation and disaggregation. The cells were then strained
through 70 mm nylon gauze and centrifuged at 400  g through 400
mL of FCS containing 10 mM EDTA. To ensure that only intracellular
beads were assessed by flow cytometry, single cells were incu-
bated with 1 mL of 20 mM EDTA in PBS for 20 min at room tem-
perature prior to labelling with the antibodies described below.
Flow cytometry Each experiment contained groups of two to four
control and two to four UV-irradiated animals. The left and right
inguinal lymph nodes from individual mice were removed and
pooled. In these experiments, mice were not sensitized to antigen.
Single cell suspensions were prepared as described above and
washed with 10% FCS/DMEM before pre–incubation at 41C for
15 min with Fc-receptor blocking antibody (clone 2.4G2). In ex-
periments analysing splenic and thymic cells, these organs were
treated in the same manner. Cells were then placed in glass tubes
for labelling with the following antibodies (clones) by four color flow
cytometry; CD4 (RM4–5), CD5 (53–7.3), CD8a (53–6.7), CD11c
(HL3), CD19 (1D3), CD43 (S7), CD80 (16–10A1), CD86 (GL1), CD90
(30-H12), I-Ab (AF6–120.1), Gr-1 (RB6–8C5), IgD (11–26c.2a), IgM
(II/41), and B220 (RA3–6B2) (all from Pharmingen, Franklin Lakes,
New Jersey). Isotype control antibodies were used in parallel to
ensure antibody specificity. Isotype control labelling was also used
to produce the electronic gates for analysis of positively labelled
cells. Streptavidin allophycocyanate (Pharmingen) was routinely
used to label biotinylated primary antibodies. 106 cells in 100 mL of
primary or isotype control antibody at the same protein concen-
tration (1–2 mg antibody per 106 cells) were incubated for 45 min at
41C. Cells were then washed by underlaying with 400 mL of FCS
and spun at 420  g before resuspending in 400 mL of fresh
DMEM/10% FCS for flow cytometry. Acquisition was performed on
a FACSCalibur Flow Cytometer (Becton Dickinson, BD Franklin
Lakes, New Jersey) and populations were analyzed using Cell-
Quest Pro software (BD).
Cell puriﬁcation and adoptive transfer Draining inguinal lymph
nodes pooled from either UV-irradiated or control unirradiated
mice were made into single cell suspensions as described above.
In these experiments, mice were not sensitized to antigen; the
lymph nodes drain the site of UV exposure. CD11c and CD90 im-
munomagnetic beads were then used to purify CD11cþ DC,
CD11c–CD90– B cells, or CD11c–CD90þ T cells (MACS beads;
Miltenyi Biotec, Auburn, California). Purified cells were conjugated
to the antigen TNP in vitro as we have described previously (Halli-
day et al, 1988). Briefly, cells were diluted to 107 cells per mL, an
equal volume of 20 mM tri-nitro-benzene-sulfonic acid (ICI Chem-
ical) in Hanks-buffered salt solution (HBSS) were added, and the
cells were incubated for 10 min at 371C. Cells were washed three
times in 10% FCS/HBSS before resuspending in sterile HBSS. 105
APC and/or T cells (either DC or B cells by themselves or a co-
transfer of cells in various combinations) in 200 mL HBSS were then
injected i.v. into naI¨ve syngeneic hosts. Seven days after injection
of cells, the immune response was elicited by challenging both
sides of one ear with 10 mL of a 1% TNCB solution and CS was
measured 24 h later. The difference in thickness between the
challenged and unchallenged ears was then read 24 h later in a
blinded fashion. Irritant negative control mice were challenged with
10 mL of 1% TNCB on each side of the ear but without prior sen-
sitization. To verify that any changes were independent of the an-
tigen used, a different contact antigen (FITC) was used in separate
experiments. The method used to conjugate FITC to APC in vitro
was similar to that above and has been described elsewhere
(Knight et al, 1998).
IL-10 treatment of adoptively transferred B cells B cells were
purified from the inguinal lymph nodes of unsensitized, unirradiated
mice using CD11c and CD90 microbeads as described above.
2  105 purified B cells were then incubated in 96-well plates for 24
h with either complete RPMI/10% FCS media only (Invitrogen
Corporation, Melbourne, VIC, Australia), or RPMI/10% FCS media
containing 20 ng per mL of IL-10 (R&D Systems, Minneapolis,
Minnesota) as described previously (Go et al, 1990). IL-10 was
then removed by thoroughly washing the B cells four times with
10% FCS/HBSS. A sample of the B cells was stained for IgD,
CD11c, B220, and MHC II to assess their activation state by flow
cytometry. The remaining B cells were co-injected with freshly
isolated, TNP-conjugated DC as described above. Seven days
later, the immune response to TNP was measured by challenging
the ears of mice with TNCB by a conventional contact hypersen-
sitivity assay.
Statistical analysis For analysis of cell numbers, percentages
and fluorescence intensities within lymphoid organs, an unpaired
two-tailed Student’s t test was used, where po0.05 was con-
sidered statistically significant. In the adoptive transfer experi-
ments, immunity was defined as the ability of the APC to induce a
significant CS to TNCB challenge above irritant negative control
groups. Statistical analysis was carried out using an analysis of
variance (ANOVA; Fisher’s PLSD), with po0.05 considered statis-
tically significant.
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